| Initial public offer of up to [*] equity shares of face value of Re. 1/- each ("Equity Shares") of Sudeep Pharma Limited ("Company") for cash at a price of Rs. [*] per equity share (Including a Share Premium of Rs. [*] per Equity Share) ("Offer Price") aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1/- aggregating up to Rs. 95.00 crores by the company ("Fresh Issue") and an offer for sale of up to 10,076,492 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores ("Offered Shares") by the selling shareholders, consisting of up to 3,567,670 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Sujit Jaysukh Bhayani*, up to 5,004,622 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Sujeet Jaysukh Bhayani HUF, up to 750,000 equity shares of face value of Re. 1/- aggregating up to Rs. [*] crores by Shanil Sujit Bhayani** and up to 754,200 equity shares of face value of Re.1/- aggregating up to Rs.[*] crores by Avani Sujit Bhayani** (Collectively "the Selling Shareholders") and such equity shares offered by the selling shareholders ("Offer for Sale", and together with the fresh issue, the "Offer").
The company, in consultation with the brlms, may consider an issue of specified securities aggregating up to Rs. 19.00 crores, as may be permitted under applicable law, prior to filing of the
("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken).
The face value of equity shares is Re. 1/- each. the offer price is [*] times the face value of the equity shares.
The price band and the minimum bid lot will be decided by the company. |